Find clinical trials for Pancreatic Cancer in New Haven, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near New Haven, CT, USA:
The purpose of this study is to evaluate the safety or treating pancreatic cancer with surgery to remove cancerour tissue, followed...
Phase 1
Commack, New York, United States and 6 other locations
Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...
Phase 2
Meriden, Connecticut, United States and 135 other locations
phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety pr...
Phase 1
New Haven, Connecticut, United States and 65 other locations
and clinical activity of AB680 in combination with Zimberelimab (AB122), nab-paclitaxel and gemcitabine in participants with advanced pancreatic...
Phase 1
New Haven, Connecticut, United States and 17 other locations
or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...
Phase 2, Phase 3
New Haven, Connecticut, United States and 91 other locations
treatment for people with locally advanced or borderline resectable pancreatic cancer. The researchers will also look at the safety...
Phase 1, Phase 2
Commack, New York, United States and 6 other locations
This study is open to adults with advanced pancreatic cancer for whom previous treatment was not successful or no treatment exists. ...
Phase 1
New Haven, Connecticut, United States and 11 other locations
This trial will study tisotumab vedotin to find out whether it is an effective treatment alone or with other anticancer drugs for certain solid tumors...
Phase 2
New Haven, Connecticut, United States and 71 other locations
This study is an open-label, international, multi-center, Phase 1 study in adult patients with solid tumors likely to express CLDN18.2....
Phase 1
New Haven, Connecticut, United States and 19 other locations
is to evaluate the safety and tolerability of RMC-9805 as monotherapy and in combination with RMC-6236 in adults with KRAS G12D-mutant solid tumors...
Phase 1
New Haven, Connecticut, United States and 16 other locations
Clinical trials
Research sites
Resources
Legal